Labcorp expands digital pathology partnership with PathAI's AISight Dx

Through an expanded collaboration, Labcorp will deploy the FDA-approved AISight Dx platform across its anatomic pathology labs, enabling fully digital workflows, improved collaboration, and enhanced diagnostic efficiency.
Feb. 27, 2026

Labcorp announced an expanded collaboration with PathAI to deploy AISight Dx, an FDA-cleared digital pathology platform, across its national network of anatomic pathology labs and hospital collaborations. The cloud-based technology allows pathologists to view and manage slides digitally and use AI to support key steps in the diagnostic process.

Labcorp will deploy AISight Dx across its anatomic pathology labs and hospital collaborations, enabling fully digital workflows for case management, slide review, collaboration and annotation. The platform also integrates AI-powered image analysis, secure storage and system connectivity to deliver faster turnaround, greater efficiency, reliable quality and improved collaboration. Labcorp will also incorporate digital pathology workflows in support of its precision medicine products.

Visit Labcorp for more information

About the Author

Sign up for our eNewsletters
Get the latest news and updates